Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard K Wyse

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The European Journal of Neuroscience|October 1, 2018
The Linked Clinical Trials initiative (LCT) for Parkinson's diseasePatrik Brundin, Richard K Wyse
Journal of Parkinson'S Disease|July 20, 2016
Nilotinib - Differentiating the Hope from the HypeRichard K Wyse, Patrik Brundin, Todd B Sherer
Frontiers in Neuroscience|April 5, 2021
Drug Repurposing for Parkinson's Disease: The International Linked Clinical Trials experienceSimon R W Stott, Richard K Wyse, Patrik Brundin
Progress in Brain Research|April 6, 2020
Novel approaches to counter protein aggregation pathology in Parkinson's diseaseSimon R W Stott, Richard K Wyse, Patrik Brundin
Iranian Journal of Kidney Diseases|January 6, 2012
Cellular and molecular aspects of Goodpasture syndromeFaris Q Alenzi, Mohamed L Salem, Fawwaz A Alenazi, et al.
Saudi Medical Journal|July 3, 2007
A close link between Fas, p53 and Apaf-1 in chronic myeloid leukemiaFaris Q Alenzi, Richard K Wyse, Waleed G Tamimi, et al.
Brain Communications|January 4, 2021
The Parkinson's Disease Comprehensive Response (PDCORE): a composite approach integrating three standard outcome measuresMatthias Luz, Alan Whone, Niccolò Bassani, et al.
Journal of Parkinson'S Disease|June 21, 2021
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2021 UpdateKevin McFarthing, Gary Rafaloff, Marco A S Baptista, et al.
Journal of Parkinson'S Disease|August 4, 2020
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2020Kevin McFarthing, Sue Buff, Gary Rafaloff, et al.
Journal of Parkinson'S Disease|May 9, 2022
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2022 UpdateKevin McFarthing, Gary Rafaloff, Marco Baptista, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The European Journal of Neuroscience|October 1, 2018
The Linked Clinical Trials initiative (LCT) for Parkinson's diseasePatrik Brundin, Richard K Wyse
Journal of Parkinson'S Disease|July 20, 2016
Nilotinib - Differentiating the Hope from the HypeRichard K Wyse, Patrik Brundin, Todd B Sherer
Frontiers in Neuroscience|April 5, 2021
Drug Repurposing for Parkinson's Disease: The International Linked Clinical Trials experienceSimon R W Stott, Richard K Wyse, Patrik Brundin
Progress in Brain Research|April 6, 2020
Novel approaches to counter protein aggregation pathology in Parkinson's diseaseSimon R W Stott, Richard K Wyse, Patrik Brundin
Iranian Journal of Kidney Diseases|January 6, 2012
Cellular and molecular aspects of Goodpasture syndromeFaris Q Alenzi, Mohamed L Salem, Fawwaz A Alenazi, et al.
Saudi Medical Journal|July 3, 2007
A close link between Fas, p53 and Apaf-1 in chronic myeloid leukemiaFaris Q Alenzi, Richard K Wyse, Waleed G Tamimi, et al.
Brain Communications|January 4, 2021
The Parkinson's Disease Comprehensive Response (PDCORE): a composite approach integrating three standard outcome measuresMatthias Luz, Alan Whone, Niccolò Bassani, et al.
Journal of Parkinson'S Disease|June 21, 2021
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2021 UpdateKevin McFarthing, Gary Rafaloff, Marco A S Baptista, et al.
Journal of Parkinson'S Disease|August 4, 2020
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2020Kevin McFarthing, Sue Buff, Gary Rafaloff, et al.
Journal of Parkinson'S Disease|May 9, 2022
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2022 UpdateKevin McFarthing, Gary Rafaloff, Marco Baptista, et al.
Pageof 3